Home › Trial NCT02766348
Clinical Efficacy and Safety of Dendritic Cytotoxic Lymphocyte(DC-CTL) Cell Infusion in NSCLC Patients
- Trial IDNCT02766348
- StatusUnknown
- PhasePhase 2
- Study typeInterventional
- SponsorShenzhen Hornetcorn Bio-technology Company, LTD
- Enrollment60
- Start date2016-05
- ConditionsNSCLC
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.